Spherix Global Insights

January 01, 1970

RealTime Dynamix™: Bone and Mineral Metabolism US Q1 2019 Spotlight

RealTime Dynamix™: Bone and Mineral Metabolism US Q1 2019 Spotlight

https://www.spherixglobalinsights.com/wp-content/uploads/2019/06/rtd-bone-q1-2019.pngDownload Report Spotlight

Last month Spherix surveyed 201 US nephrologists about their management of secondary hyperparathyroidism, vitamin D insufficiency, and hyperphosphatemia in the dialysis and non-dialysis settings. See complimentary highlights from the Q2 2018 wave of RealTime Dynamix™: Bone and Mineral Metabolism US below.

Contact info@spherixglobalinsights.com for more information about the highlighted report or to see if your company already has access to the report series.

https://www.spherixglobalinsights.com/wp-content/uploads/2019/06/Spotlight_RTD_Bone-and-Mineral-Metabolism_Q1_2019.png

All company, brand or product names and logos in this document are trademarks of their respective holders.